Skip to content

Piloting a Dietary Vitamin E Intervention During Pregnancy

A Double Blind Randomised Placebo Controlled Pilot Study of a Dietary Soup Intervention During Pregnancy to Optimise Dietary Vitamin E Intake in Relation to Childhood Asthma.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01661530
Enrollment
59
Registered
2012-08-09
Start date
2012-12-31
Completion date
2014-01-31
Last updated
2014-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, pregnancy, diet, vitamin E

Brief summary

In the last forty years the prevalence of asthma has increased in westernised countries. We have hypothesised that this increase may be a consequence of changing diet. Several birth cohort studies have now reported an association between reduced maternal vitamin E intake during pregnancy and childhood asthma. However, it remains to be seen whether increasing maternal vitamin E intake during pregnancy reduces the risk of childhood asthma. We are planning a large placebo controlled trial in pregnant women, to investigate whether optimisation of dietary vitamin E intake to the recommended 15mg/day reduces the likelihood of childhood asthma. We believe that a dietary intervention using vitamin E in its natural form of food is more likely to be successful and acceptable than a vitamin E supplement. We have previously demonstrated than pregnant women can optimise their vitamin E intake using a personalised dietary plan with the help of a dietitian however this intervention was complex and could not be translated into everyday use. With commercial support we have developed a range of soups containing foods naturally rich in vitamin E designed to optimise maternal vitamin E intake to 15mg/day. A range of similar tasting and looking placebo soups has also been developed. In this study we will pilot a randomised controlled trial of the active and placebo soups to ascertain whether pregnant women are willing and able to optimise their vitamin E intake during pregnancy using the soups in order to reduce the risk of their child developing asthma. optimising maternal vitamin E intake during pregnancy.

Interventions

DIETARY_SUPPLEMENTVitamin E enhanced soup

vitamin E enhancement is by virtue of the natural vitamin E content of the food ingredients

DIETARY_SUPPLEMENTNon-enhanced soups

Similar looking and tasting soups with low vitamin E content by virtue of food ingredients

Sponsors

University of Aberdeen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* 10-12 weeks pregnant. * Routine low risk antenatal care. * A personal or partner history of asthma at anytime. * Able and willing to give informed consent to participate * Able and willing to participate in the study procedures

Exclusion criteria

* Use of vitamin E supplements. * A history of diabetes, coagulopathies or use of anticoagulants, use of clopidogrel, cholestyramine, cyclosporin A, gemfibrozil, isoniazid, orlistat, anticonvulsants. * Any other significant disease or disorder which, in the opinion of the investigator, either puts the woman at risk because of participating in the study or may influence the results of the study, or the woman's ability to participate in the study. * Participating in another clinical study * Previous allocation of randomisation code in the study.

Design outcomes

Primary

MeasureTime frame
Participation of pregnant women in a randomised trial of enhanced and placebo soups from 12 weeks gestation until delivery.1 year

Secondary

MeasureTime frame
Dietary vitamin E intake during pregnancy.1 year
Lung function of new born infants.1 year

Other

MeasureTime frame
Biomarker of dietary compliance1 year

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026